Fragile X Syndrome: Research and Perspectives
Saturday, September 6, 2014
The Future of Fragile X Public Health Research
This message from the interim executive director of the National Fragile X Foundation (NFXF) describes how clinical trials of new drugs have been successful in animals thus far, though he does not believe the foundation has the tools necessary to measure the effectiveness of the drugs in humans. By obtaining sample observations from a large population over a period of time, the NFXF will better be able to "catalog" the impact of Fragile X syndrome in individuals, thereby making it easier to test the effectiveness of these experimental drugs.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment